Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures

• Joo Sang Lee ^[1] ; Lital Adler ^[2] ; Hiren Karathia ^[3]
  1. [1] National Institutes of Health

     National Institutes of Health

     Estados Unidos

     
  2. [2] Weizmann Institute of Science

     Weizmann Institute of Science

     Israel

     
  3. [3] University of Maryland Institute for Advanced Computer Studies

  Mostrar afiliaciones +
• Localización: Cell, ISSN 0092-8674, Vol. 174, Nº. 6, 2018, págs. 1559-1570
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • The urea cycle (UC) is the main pathway by which mammals dispose of waste nitrogen. We find that specific alterations in the expression of most UC enzymes occur in many tumors, leading to a general metabolic hallmark termed “UC dysregulation” (UCD). UCD elicits nitrogen diversion toward carbamoyl-phosphate synthetase2, aspartate transcarbamylase, and dihydrooratase (CAD) activation and enhances pyrimidine synthesis, resulting in detectable changes in nitrogen metabolites in both patient tumors and their bio-fluids. The accompanying excess of pyrimidine versus purine nucleotides results in a genomic signature consisting of transversion mutations at the DNA, RNA, and protein levels. This mutational bias is associated with increased numbers of hydrophobic tumor antigens and a better response to immune checkpoint inhibitors independent of mutational load. Taken together, our findings demonstrate that UCD is a common feature of tumors that profoundly affects carcinogenesis, mutagenesis, and immunotherapy response.